Institute For Wealth Management »

SPDR S&P Pharmaceuticals shares owned by Institute For Wealth Management

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Institute For Wealth Management from 13F filings

Historical chart of Institute For Wealth Management investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Institute For Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Institute For Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $86k 1.3k 66.27
2019-12-31 $34k 741 45.88

More positions owned by Institute For Wealth Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Lam Research Corp Com New (LRCX)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Advanced Micro Devices (AMD)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Applied Materials (AMAT)
Tesla Motors (TSLA)
Vaneck Etf Trust Semiconductr Etf (SMH)
Axon Enterprise (AXON)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Goldman Sachs (GS)

View all positions for Institute For Wealth Management

Top funds holding SPDR S&P Pharmaceuticals

Bank of America Corporation
CWM
Wells Fargo & Company
Kingsview Wealth Management
Morgan Stanley
Envestnet Asset Management
First Citizens Bank & Trust
Envestnet Portfolio Solutions
LPL Financial
Susquehanna International
Branch Banking & Trust Company
Cetera Investment Advisers
Private Advisor
Two Sigma Investments
Citigroup

View all funds holding SPDR S&P Pharmaceuticals